Lorenza Rimassa


Ontology type: schema:Person     


Person Info

NAME

Lorenza

SURNAME

Rimassa

Publications in SciGraph latest 50 shown

  • 2021-08-05 Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma in CLINICAL DRUG INVESTIGATION
  • 2021-06-21 Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma in DRUGS & AGING
  • 2021-03-24 NASH limits anti-tumour surveillance in immunotherapy-treated HCC in NATURE
  • 2021-03-20 Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2021-02-08 Pembrolizumab-Induced Vanishing Bile Duct Syndrome: a Case Report in SN COMPREHENSIVE CLINICAL MEDICINE
  • 2021-02-03 Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study in BRITISH JOURNAL OF CANCER
  • 2021-02-02 Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? in MEDICAL ONCOLOGY
  • 2021-01-03 Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study in SUPPORTIVE CARE IN CANCER
  • 2020-10-19 Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study in BRITISH JOURNAL OF CANCER
  • 2020-06-10 Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2020-05-19 The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials in BRITISH JOURNAL OF CANCER
  • 2020-03-23 Metabolic Switch in Hepatocellular Carcinoma Patients Treated with Sorafenib: a Proof-of-Concept Trial in MOLECULAR IMAGING AND BIOLOGY
  • 2020-03-10 Immune-based therapies for hepatocellular carcinoma in ONCOGENE
  • 2019-09-02 CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2019-03-29 Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial in BMC CANCER
  • 2018-11-13 Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma in BRITISH JOURNAL OF CANCER
  • 2018-03-27 Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study in TARGETED ONCOLOGY
  • 2018-02-27 Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? in ANNALS OF SURGICAL ONCOLOGY
  • 2018-02-08 Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases in WORLD JOURNAL OF SURGERY
  • 2017-10-16 High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models in LABORATORY INVESTIGATION
  • 2016-12-27 Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world in GASTRIC CANCER
  • 2016-08-16 Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications in GASTRIC CANCER
  • 2015-05-12 Diagnostic accuracy of 11C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2014-09-23 Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2014-08-27 Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach in BMC CANCER
  • 2013-07-03 Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT in TARGETED ONCOLOGY
  • 2013-06-21 SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience in RADIATION ONCOLOGY
  • 2013-04-09 Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2013-01-03 A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis in BRITISH JOURNAL OF CANCER
  • 2010-08-17 Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma in BRITISH JOURNAL OF CANCER
  • 2010-06-25 Adrenal metastases from adenocarcinoma of the esophagogastric junction: adrenalectomy and long-term survival in UPDATES IN SURGERY
  • 2010-06-15 Rectal squamous cell carcinoma treated with chemoradiotherapy: report of six cases in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2008-06-24 Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients in BRITISH JOURNAL OF CANCER
  • 2007-05-11 The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study in INVESTIGATIONAL NEW DRUGS
  • 2005-09-19 Oral ulcer as an exclusive sign of gastric cancer: report of a rare case in BMC CANCER
  • 2004-04-26 Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer in BONE MARROW TRANSPLANTATION
  • 2003-01 Unexpected Low Efficacy of Stealth Liposomal Doxorubicin (Caelyx) and Vinorelbine in Metastatic Breast Cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 1997 Serum Markers of Bone Metastases in Postmenopausal Breast Cancer Patients Treated with Formestane in TUMOR BIOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.417728.f", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.18887.3e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.452490.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410345.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411482.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5072.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.460094.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413629.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419425.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410914.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411693.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7841.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.258622.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415431.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.134563.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.425866.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4708.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.428496.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415257.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.25879.31", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.34477.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415854.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4305.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415093.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414603.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4527.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5963.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7708.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.459379.5", 
            "type": "Organization"
          }
        ], 
        "familyName": "Rimassa", 
        "givenName": "Lorenza", 
        "id": "sg:person.0733441746.71", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0001-9957-3615"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733441746.71", 
          "https://orcid.org/0000-0001-9957-3615"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-01-01T19:59", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/person/person_986.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0733441746.71'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0733441746.71'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0733441746.71'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0733441746.71'


     

    This table displays all metadata directly associated to this object as RDF triples.

    81 TRIPLES      11 PREDICATES      43 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.0733441746.71 schema:affiliation N43ca2722e8a64a22aa6e30aa07d90ee4
    2 grid-institutes:grid.134563.6
    3 grid-institutes:grid.18887.3e
    4 grid-institutes:grid.258622.9
    5 grid-institutes:grid.25879.31
    6 grid-institutes:grid.34477.33
    7 grid-institutes:grid.410345.7
    8 grid-institutes:grid.410914.9
    9 grid-institutes:grid.411482.a
    10 grid-institutes:grid.411693.8
    11 grid-institutes:grid.413629.b
    12 grid-institutes:grid.414603.4
    13 grid-institutes:grid.415093.a
    14 grid-institutes:grid.415257.0
    15 grid-institutes:grid.415431.6
    16 grid-institutes:grid.415854.9
    17 grid-institutes:grid.417893.0
    18 grid-institutes:grid.419425.f
    19 grid-institutes:grid.425866.b
    20 grid-institutes:grid.428496.5
    21 grid-institutes:grid.4305.2
    22 grid-institutes:grid.452490.e
    23 grid-institutes:grid.4527.4
    24 grid-institutes:grid.459379.5
    25 grid-institutes:grid.460094.f
    26 grid-institutes:grid.4708.b
    27 grid-institutes:grid.5072.0
    28 grid-institutes:grid.5963.9
    29 grid-institutes:grid.7445.2
    30 grid-institutes:grid.7708.8
    31 grid-institutes:grid.7841.a
    32 schema:familyName Rimassa
    33 schema:givenName Lorenza
    34 schema:identifier Nba3220d81f1c494b82b17b6a853a6b43
    35 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733441746.71
    36 https://orcid.org/0000-0001-9957-3615
    37 schema:sdDatePublished 2022-01-01T19:59
    38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    39 schema:sdPublisher Na7b40a9c582b47b3b9d7cd529e1f35d6
    40 sgo:license sg:explorer/license/
    41 sgo:sdDataset persons
    42 rdf:type schema:Person
    43 N43ca2722e8a64a22aa6e30aa07d90ee4 schema:affiliation grid-institutes:grid.417728.f
    44 sgo:isCurrent true
    45 rdf:type schema:OrganizationRole
    46 Na7b40a9c582b47b3b9d7cd529e1f35d6 schema:name Springer Nature - SN SciGraph project
    47 rdf:type schema:Organization
    48 Nba3220d81f1c494b82b17b6a853a6b43 schema:name orcid_id
    49 schema:value 0000-0001-9957-3615
    50 rdf:type schema:PropertyValue
    51 grid-institutes:grid.134563.6 schema:Organization
    52 grid-institutes:grid.18887.3e schema:Organization
    53 grid-institutes:grid.258622.9 schema:Organization
    54 grid-institutes:grid.25879.31 schema:Organization
    55 grid-institutes:grid.34477.33 schema:Organization
    56 grid-institutes:grid.410345.7 schema:Organization
    57 grid-institutes:grid.410914.9 schema:Organization
    58 grid-institutes:grid.411482.a schema:Organization
    59 grid-institutes:grid.411693.8 schema:Organization
    60 grid-institutes:grid.413629.b schema:Organization
    61 grid-institutes:grid.414603.4 schema:Organization
    62 grid-institutes:grid.415093.a schema:Organization
    63 grid-institutes:grid.415257.0 schema:Organization
    64 grid-institutes:grid.415431.6 schema:Organization
    65 grid-institutes:grid.415854.9 schema:Organization
    66 grid-institutes:grid.417728.f schema:Organization
    67 grid-institutes:grid.417893.0 schema:Organization
    68 grid-institutes:grid.419425.f schema:Organization
    69 grid-institutes:grid.425866.b schema:Organization
    70 grid-institutes:grid.428496.5 schema:Organization
    71 grid-institutes:grid.4305.2 schema:Organization
    72 grid-institutes:grid.452490.e schema:Organization
    73 grid-institutes:grid.4527.4 schema:Organization
    74 grid-institutes:grid.459379.5 schema:Organization
    75 grid-institutes:grid.460094.f schema:Organization
    76 grid-institutes:grid.4708.b schema:Organization
    77 grid-institutes:grid.5072.0 schema:Organization
    78 grid-institutes:grid.5963.9 schema:Organization
    79 grid-institutes:grid.7445.2 schema:Organization
    80 grid-institutes:grid.7708.8 schema:Organization
    81 grid-institutes:grid.7841.a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...